| Product Code: ETC11832270 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell Gene Therapy Manufacturing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 India Cell Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 India Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Cell Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in healthcare infrastructure in India |
4.2.2 Growing demand for personalized medicine and advanced therapies |
4.2.3 Favorable government initiatives and policies supporting cell gene therapy manufacturing in India |
4.3 Market Restraints |
4.3.1 Lack of skilled workforce and expertise in cell gene therapy manufacturing |
4.3.2 High initial investment and operational costs associated with setting up manufacturing facilities |
4.3.3 Stringent regulatory requirements and approval processes for cell gene therapy products in India |
5 India Cell Gene Therapy Manufacturing Market Trends |
6 India Cell Gene Therapy Manufacturing Market, By Types |
6.1 India Cell Gene Therapy Manufacturing Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Cell Expansion Systems, 2021 - 2031F |
6.1.4 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Gene Editing Platforms, 2021 - 2031F |
6.1.5 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Cryopreservation Solutions, 2021 - 2031F |
6.1.6 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Fill-Finish Services, 2021 - 2031F |
6.2 India Cell Gene Therapy Manufacturing Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Bioreactor-Based Expansion, 2021 - 2031F |
6.2.3 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Zinc Finger Nucleases, 2021 - 2031F |
6.2.4 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Liquid Nitrogen Storage, 2021 - 2031F |
6.2.5 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Sterile Filling and Packaging, 2021 - 2031F |
6.3 India Cell Gene Therapy Manufacturing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By CDMOs and Pharma Companies, 2021 - 2031F |
6.3.3 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Research Laboratories, 2021 - 2031F |
6.3.4 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Cell Banks and Biorepositories, 2021 - 2031F |
6.3.5 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Hospitals and Clinical Centers, 2021 - 2031F |
6.4 India Cell Gene Therapy Manufacturing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Scalable Cell Therapy Manufacturing, 2021 - 2031F |
6.4.3 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Genetic Modification for Therapies, 2021 - 2031F |
6.4.4 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Long-Term Storage of CGT Products, 2021 - 2031F |
6.4.5 India Cell Gene Therapy Manufacturing Market Revenues & Volume, By Final Product Delivery to Patients, 2021 - 2031F |
7 India Cell Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 India Cell Gene Therapy Manufacturing Market Export to Major Countries |
7.2 India Cell Gene Therapy Manufacturing Market Imports from Major Countries |
8 India Cell Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of collaborations and partnerships between Indian and international biotech companies for technology transfer and knowledge sharing |
8.2 Percentage increase in government funding for research and development in cell gene therapy manufacturing |
8.3 Number of research publications and patents related to cell gene therapy manufacturing originating from India |
9 India Cell Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 India Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Cell Gene Therapy Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Cell Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 India Cell Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 India Cell Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here